Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Deputy Prime Minister Highlights Trimega Laboratories' Investment in Brazil


News provided by

Trimega Laboratories

22 Jun, 2011, 15:18 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, June 22, 2011 /PRNewswire/ --

- Trimega Partners With Brazil's Laboratório Sodré to Test Hair Samples of Brazilian Police for Evidence of Drug Abuse

- Trimega Plans to Open "Super Laboratory" in Brazil for Hair Drug Tests

  

Nick Clegg, the Deputy Prime Minister, today highlighted Trimega Laboratories' investment in Brazil during a keynote speech in Brasilia during the UK trade delegation's visit to the country.  Trimega, one of the world's leading companies for testing hair for substance abuse, has signed a partnership with Laboratório Sodré of São Paulo, Brazil, to conduct tests on Brazilian hair samples for evidence of drug misuse.  Trimega also plans to open a Brazilian "Super Laboratory" for hair drug and alcohol testing in the next 18 months.

Initially, Trimega will test hair samples for the Brazilian police force at its state-of-the art laboratory in Manchester, which was opened in February, following a £1m (R$2.6m) investment by the company.  Trimega will review the hair for a comprehensive range of drugs, including amphetamines, crack, cocaine, marijuana and other opiates.

UK Trade Investment, the UK's leading body for promoting UK exports, introduced Trimega to Laboratório Sodré.

John Doddrell, Director of UK Trade & Investment in Brazil, said: "Trimega is an established UK leader for drug and alcohol testing of hair. We are very pleased to have helped a British company with such cutting edge capacity to find a valuable Brazilian partner, and to develop bilateral cooperation in science and business between the two countries."

Avi Lasarow, CEO of Trimega Laboratories, said: "We are delighted to partner with Laboratório Sodré and that the Deputy Prime Minister spoke about our investment in Brazil during his speech in Brasilia.  We look forward to the first samples from Brazil arriving in our Manchester laboratory, developing Brazil's first superlab for drug and alcohol testing compliance, and creating jobs for the local economy."

Mr.Sodré, CEO of Laboratório Sodré, said:  "Trimega Laboratories is one of the most advanced laboratories of its kind in the world, with a proven track record of working with governments, the police, the aviation industry and other sectors. The company's experience and its willingness to work closely with us, together with its vision of transferring its knowledge to us, made Trimega the natural partner."

Hair drug testing is a revolutionary method of testing for drugs using hair strands.  It not only determines the presence of an illegal substance, but can also provide an accurate historical record of substance misuse. This helps in differentiating between a one-off user and a chronic substance abuser.  Hair drug testing covers up to 12 months depending on the type and length of hair of the donor.  More traditional forms of testing, such as analysis of urine and blood, can provide a record of consumption of only the previous three days and four to six weeks, respectively.  Approximately 1.3cm of hair is required for one month of results.

Trimega has the latest mass spectrometry techniques to accurately determine drug usage to very small detectable levels, including High Performance Liquid Chromatography tandem mass spectrometry (HPLC/MS/MS) and the gas chromatographic equivalent (GC/MS/MS). These techniques are often referred to as the 'Platinum Standard' when compared with traditional GC/MS analysis, and enable analysis of positive and negative results.  Most laboratories in the USA do not combine both testing techniques.

Trimega already tests for nearly half of the UK market for hair tests, working mostly with the legal sector and social services, and is growing rapidly.

The Cabinet Office's announcement about the Deputy Prime Minister's speech can be seen at the following link:   http://www.dpm.cabinetoffice.gov.uk/news/new-era-uk-brazil-relations.

About Laboratório Sodré (http://www.laboratoriosodre.com.br/novo )

Established in 1985 by bio physician Claudio Ariano Sodré, Laboratório Sodré was founded with the aim of providing accurate clinical analysis to clients across the medical establishment.

The company aims to provide high levels of technical, ethical and moral service to clients, in accordance with the standards established by the Brazilian Clinical Pathology Society.

The business has steadily grown to its current size of eight service units and offers over 3,000 tests in the clinical analysis field, as well as other divisions that work in the fields of toxicological testing, occupational medicine, and DNA testing.

The company uses state-of-the-art technology to provide efficiency and efficacy. It provides results via e-mail and offers individualised access via the internet to clients and physicians.

Investment in human capital is extremely important to Laboratório Sodré, and it invests in continual professional development - there are now more than 40 professionals employed by Laboratório Sodré: bio physicians, biologists, nurses and nursing technicians, all trained to deliver excellent results to clients and physicians.

About Trimega Laboratories (http://www.trimegalabs.co.uk)

Established in London in 2005, Trimega Laboratories is well recognised for being a leader in the development of innovative techniques for testing for substances of abuse. Its core business is laboratory-based analysis of hair samples that provide accurate historical records of alcohol or drugs dependency over a one to 12 month period. In the UK, Trimega's core clients include: family law specialists, law courts, and social services.  

Trimega was the first to market with dual marker hair alcohol testing (FAEE and EtG). Dual hair testing provides very accurate results: at its annual conference in March 2011, the Society of Hair Testing (SoHT) confirmed that dual testing on hair for alcohol misuse provides accuracy rates of over 94% for false negatives and over 99% for false positives.  The SoHT's consensus was based on analysis of Trimega's data set of approximately 2,000 dual hair testing samples, the largest of its kind in the world.

Other services offered by Trimega include: Roadside Drugalyzer Testing for law enforcement, Hair Steroid Testing for athletes, and Hair Benzodiazepines Testing.

Trimega won the title of Best Use of Technology in the 2008 Barclays-sponsored Startups Awards, and has been on the shortlist for the National Business Awards three years running. Trimega is also one of 25 companies to represent the UK in the 2011 European Business Awards.

Trimega conducts its hair alcohol analysis in laboratories in Germany which are accredited with international standard ISO 17025 by DAkkS, the German issuing authority, equivalent to UKAS in the UK. The technology for hair-alcohol testing originated in Germany.

The UK Ministry of Justice does not require hair testing laboratories to be accredited. However, Trimega's UK laboratory in Manchester, which carries out drug tests, operates to ISO 17025 standards, and has applied for ISO 17025 accreditation from UKAS. Trimega's Manchester laboratory already has IS0 9001:2008 certification from Lloyd's Register Group, itself accredited by UKAS, for the 'provision of clinical collecting, testing, analysis and interpretation services for substances of abuse'.  In addition, the Manchester laboratory is the only UK laboratory in the industry to have ISO 14001 certification from QMS International, the environmental management system standard for internal quality management. Trimega is an Investor in People.

Trimega was responsible for the creation of a Hair Strand Scientific Advisory Board. Its purpose is to analyse the fast growing database of information created from the 10,000 hair alcohol tests and 7,000 hair drug tests carried out on UK samples each year, of which Trimega is responsible for around 40%. The findings of the Board are shared with the Society of Hair Testing which will assist it in future decisions, particularly those relating to the setting of universal standards/guidelines.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.